Ironwood Pharmaceuticals (IRWD) Intangibles (2016 - 2026)

Ironwood Pharmaceuticals has disclosed Intangibles across 7 years of filings, most recently posting $1.6 million for Q2 2026.

• In Q2 2026, Intangibles fell 33.43% year-over-year to $1.6 million; the TTM figure through Jun 2026 stood at $1.6 million (down 33.43% YoY), while the FY2025 annual figure was $2.0 million, down 28.67% from the prior year.
• Intangibles came in at $1.6 million for Q2 2026 at Ironwood Pharmaceuticals, down from $1.8 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $4.1 million in Q2 2023 to a low of $1.6 million in Q2 2026.
• Average Intangibles over 4 years is $2.9 million, with a median of $2.9 million recorded in 2024.
• Year-over-year, Intangibles declined 20.09% in 2024 and tumbled 33.43% in 2026.
• Over 4 years, Intangibles stood at $3.7 million in 2023, then slipped by 22.32% to $2.9 million in 2024, then decreased by 28.67% to $2.0 million in 2025, then fell by 19.95% to $1.6 million in 2026.
• Per Business Quant data, the three most recent Intangibles figures were $1.6 million in Q2 2026, $1.8 million in Q1 2026, and $2.0 million in Q4 2025.